World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
91
Citations
49319
World Ranking
11522
National Ranking
5910

Lawrence S. Honig publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Lawrence S. Honig sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 326 publications — 22nd percentile

22% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Lawrence S. Honig D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Lawrence S. Honig sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 91 D-Index — 43rd percentile

43% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Lawrence S. Honig is affiliated with Columbia University in the United States. Their research primarily focuses on medicine, with a strong emphasis on physiology, psychiatry and mental health, neurology, molecular biology, and cognitive neuroscience.

The scientist's work covers multiple key topics, including:

  • Alzheimer's disease research and treatments
  • Dementia and Cognitive Impairment Research
  • Functional Brain Connectivity Studies
  • Parkinson's Disease Mechanisms and Treatments
  • Advanced Neuroimaging Techniques and Applications
  • Bioinformatics and Genomic Networks
  • Health, Environment, Cognitive Aging

Lawrence S. Honig has published extensively in respected scientific venues. The most frequent publication outlets include:

  • Alzheimer s & Dementia (61 publications)
  • bioRxiv (Cold Spring Harbor Laboratory) (18 publications)
  • Nature Communications (10 publications)
  • Neurology (8 publications)
  • The Lancet Neurology (5 publications)

Their recent scientific papers demonstrate involvement in neurodegenerative disease research and genetic studies. Selected papers include:

  • Research criteria for the diagnosis of prodromal dementia with Lewy bodies, 2020, Neurology
  • Spread of pathological tau proteins through communicating neurons in human Alzheimer's disease, 2020, Nature Communications
  • Exceptionally low likelihood of Alzheimer's dementia in APOE2 homozygotes from a 5,000-person neuropathological study, 2020, Nature Communications
  • Genome sequencing analysis identifies new loci associated with Lewy body dementia and provides insights into its genetic architecture, 2021, Nature Genetics
  • A trial of gantenerumab or solanezumab in dominantly inherited Alzheimer's disease, 2021, Nature Medicine

Collaborative efforts have been significant in their career. Frequent co-authors include:

  • Clifford R. Jack
  • John C. Morris
  • Robert A. Koeppe
  • Gregory S. Day
  • Chiadi U. Onyike

Best Publications

  • Diagnosis and management of dementia with Lewy bodies Fourth consensus report of the DLB Consortium

    Ian G. McKeith;Bradley F. Boeve;Dennis W. DIckson;Glenda Halliday

  • Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study

    Maarten J Titulaer;Lindsey McCracken;Iñigo Gabilondo;Thaís Armangué

  • Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease.

    Adam C. Naj;Gyungah Jun;Gary W. Beecham;Li-San Wang

  • Two Phase 3 Trials of Bapineuzumab in Mild-to-Moderate Alzheimer's Disease

    Stephen Salloway;Reisa Sperling;Nick C. Fox;Kaj Blennow

  • Early role of vascular dysregulation on late-onset Alzheimer’s disease based on multifactorial data-driven analysis

    Y. Iturria-Medina;R. C. Sotero;P. J. Toussaint;J. M. Mateos-Pérez

  • Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease

    Rebecca Sims;Sven J. Van Der Lee;Adam C. Naj;Céline Bellenguez;Céline Bellenguez

  • Aggregation of vascular risk factors and risk of incident Alzheimer disease.

    Jose Luchsinger;Christiane Reitz;Larry S. Honig;Ming-Xin Tang

  • Trial of Solanezumab for Mild Dementia Due to Alzheimer’s Disease

    Lawrence S Honig;Bruno Vellas;Michael M Woodward;Mercè Boada

  • Hippocampal and entorhinal atrophy in mild cognitive impairment Prediction of Alzheimer disease

    D. P. Devanand;G. Pradhaban;X. Liu;A. Khandji

  • A phase 2 multiple ascending dose trial of bapineuzumab in mild to moderate Alzheimer disease.

    S. Salloway;R. Sperling;S. Gilman;N.C.I. Fox

  • Research criteria for the diagnosis of prodromal dementia with Lewy bodies

    Ian G. McKeith;Tanis J. Ferman;Alan J. Thomas;Frédéric Blanc

  • Comparative lipidomic analysis of mouse and human brain with Alzheimer disease.

    Robin B. Chan;Tiago Gil Oliveira;Etty P. Cortes;Lawrence S. Honig

  • Four distinct trajectories of tau deposition identified in Alzheimer’s disease

    Jacob W Vogel;Alexandra L Young;Neil P Oxtoby;Ruben Smith

  • Interplay of LRRK2 with chaperone-mediated autophagy

    Samantha J. Orenstein;Sheng-Hang Kuo;Inmaculada Tasset;Esperanza Arias

  • Neuropathological changes in essential tremor: 33 cases compared with 21 controls

    Elan D. Louis;Phyllis L. Faust;Jean Paul G. Vonsattel;Lawrence S. Honig

  • Plasma Aβ40 and Aβ42 and Alzheimer’s disease: Relation to age, mortality, and risk

    Richard Paul Mayeux;Lawrence S. Honig;Mingxin Tang;Jennifer J. Manly

  • Amyloid-related imaging abnormalities in patients with Alzheimer's disease treated with bapineuzumab: a retrospective analysis

    Reisa Sperling;Stephen Salloway;David J Brooks;Donatella Tampieri

  • A Multicenter Study of Glucocerebrosidase Mutations in Dementia With Lewy Bodies

    Michael A. Nalls;Raquel Duran;Grisel Lopez;Marzena Kurzawa-Akanbi

  • Model-guided microarray implicates the retromer complex in Alzheimer's disease.

    Scott A. Small;Kelly Kent;Aimee Pierce;Conrad Leung

  • Stroke and the risk of Alzheimer disease.

    Lawrence S. Honig;Mingxin Tang;Steven M. Albert;Rosanne Costa

Frequent Co-Authors

Yaakov Stern
Yaakov Stern Columbia University
John C. Morris
John C. Morris Washington University in St. Louis
Richard Mayeux
Richard Mayeux Columbia University
Jean Paul Vonsattel
Jean Paul Vonsattel Columbia University
Karen Marder
Karen Marder Columbia University
Peter St George-Hyslop
Peter St George-Hyslop Columbia University
Marilyn S. Albert
Marilyn S. Albert Johns Hopkins University School of Medicine
John Q. Trojanowski
John Q. Trojanowski University of Pennsylvania
Douglas Galasko
Douglas Galasko University of California, San Diego
Tatiana Foroud
Tatiana Foroud Indiana University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Medicine but seeking diverse career options, online degree pathways offer great flexibility and affordability. Many students are now turning to online healthcare administration programs to develop the leadership and management skills needed for administrative roles in hospitals, clinics, and health agencies.

If you are looking to further your expertise, exploring the cheapest online mha (Master’s in Healthcare Administration) options can be a smart move. Earning this degree online allows for continued professional development without pausing your career.

Aspiring nurses can advance by enrolling in the cheapest dnp online programs, achieving a Doctor of Nursing Practice with reduced tuition costs. This credential is highly valued for leadership and advanced clinical practice positions.

Finally, for those interested in pharmacy careers, there are flexible pharmacy school online options. These programs enable learners to earn advanced pharmacy credentials from the comfort of home, often at a lower price point.

Best Scientists Citing Lawrence S. Honig

Trending Scientists

Recently Published Articles